Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2010
05/19/2010CN101708171A Enteric plant hollow capsule
05/19/2010CN101708170A Alkaline effervescent tablet and preparation method thereof
05/19/2010CN101708169A Colonic targeting administration preparation containing active substance of paeonol and preparation method thereof
05/19/2010CN101708167A Intraocular nano-particle frozen-dried powder and method for preparing same
05/19/2010CN101708165A Microspheres for active embolization
05/19/2010CN101708164A Rivastigmine slow-release microspheres and preparation method thereof
05/19/2010CN101708163A Selegiline sustained release microspheres and method for preparing same
05/19/2010CN101708162A Nanoparticle and preparation method thereof
05/19/2010CN101708161A Elemene injection and preparation method thereof
05/19/2010CN101708157A Isosorbide mononitrate sodium chloride injection
05/19/2010CN101708156A Camptothecin medicament injection solution and injection and preparation method thereof
05/19/2010CN101708154A Oridonin-loaded micelle preparation and preparation method thereof
05/19/2010CN101269056B Metoprolol salt oral administration impulse pellet preparation
05/19/2010CN101240065B Sebacic anhydride and octadecane dibasic acid anhydride copolymer and its preparation method and application
05/19/2010CN101205277B Carbomer ball milling modification method
05/19/2010CN101194983B Dropping pills for treating sudden deafness and method for preparing the same
05/19/2010CN101181282B Hydroxyl radical carthamin yellow carthamus A soft capsule with high bioavailability and preparation method thereof
05/19/2010CN101129488B Traditional Chinese medicine ointment for treating burn, scald and method of producing the same
05/19/2010CN101125127B Artemisinin derivatives freeze-dried preparation and preparation method
05/19/2010CN101112620B Cisplatin-hydroxyapatite -chitose sustained-release microsphere and uses thereof
05/19/2010CN101111230B Multiparticulate pharmaceutical form comprising pellets having a modular effect in relation to active ingredient release
05/19/2010CN101107510B Method of measuring coating amount and method of estimating elution behavior
05/19/2010CN101095956B Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same
05/19/2010CN101095701B Flaky medicine containing Hirsutella hepiali - cordyceps fungus powder and method for preparing the same
05/19/2010CN101066459B Polyesthylene glycol modified zidovudine conjugate and its preparation process and application
05/19/2010CN101050062B Method for preparing slow releasing carrier of medication of microcrystalline glass in series of calcium phosphate
05/19/2010CN101049504B Carrier of liposome medication, and preparation method
05/19/2010CN101049320B Buccal tablets of extractive of propolis alcohol
05/19/2010CN101040848B Method for preparing amphiphilic nanoparticles
05/19/2010CN101032620B Cyclosporine emulsion and the preparing method
05/19/2010CN101029136B Production and use for high-oxygen light-transmittance connected network
05/19/2010CN101028461B Job's tears nut oil self-emusifying preparation and its making method
05/19/2010CN101028254B Sustaining agent of Duosuo theosine and its preparation
05/19/2010CN101019833B Oil-in-oil nonaqueous microemulsion used as medicine carrier and its medicine preparation
05/19/2010CN101011577B Polyamide dendroid polymer nano particle loading survivin small molecule RNA
05/19/2010CN101002782B Medicine composition containing ceftin cyclodextrin clathrate, and its preparing method
05/19/2010CN100998592B Microemulsion containing matrine
05/18/2010US7718797 Fasudil-containing preparation and method of improving stability thereof
05/18/2010US7718700 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors, angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents
05/18/2010US7718695 Inclusion compounds of fumagillol derivative or its salt, and pharmaceutical compositions comprising the same
05/18/2010US7718643 Pharmaceutical formulation
05/18/2010US7718640 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
05/18/2010US7718634 Method of treatment using bisphosphonic acid
05/18/2010US7718619 Abuse-resistant amphetamine prodrugs
05/18/2010US7718613 Armed peptides
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718601 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors
05/18/2010US7718599 Peptides present in form of acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salts and administration forms also contain one of above acids as free acids; for treating sex hormone-dependent diseases
05/18/2010US7718412 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin
05/18/2010US7718404 producing cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
05/18/2010US7718194 sustained-release coated particles; coating consisting of at least one cellulose-based polymer such that the release profile of a multiparticulate tablet based on these particles is identical to that of the coated particles before tabletting
05/18/2010US7718192 Tamper-resistant oral opioid agonist formulations
05/18/2010US7718190 Self forming, thermodynamically stable liposomes and their applications
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010US7718162 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
05/18/2010US7718157 Targeted lipid particles
05/18/2010CA2555429C Stable injectable diclofenac compositions
05/18/2010CA2509715C Improved thickened beverages for dysphagia
05/18/2010CA2473205C Orodispersible pharmaceutical composition comprising perindopril
05/18/2010CA2455226C Compositions comprising an o/w emulsion containing conjugated linoleic acid
05/18/2010CA2437754C Tablets quickly disintegrated in oral cavity
05/18/2010CA2424619C Method for coating fine particles with lipid membrane
05/18/2010CA2401498C New self emulsifying drug delivery system
05/18/2010CA2387536C Rate-controlled particles
05/18/2010CA2363965C Protein-induced morphogenesis
05/18/2010CA2340546C Soft capsules comprising polymers of vinyl esters and polyethers, the use and production thereof
05/18/2010CA2171266C Stable transglutaminase preparations and processes for producing them
05/17/2010CA2686135A1 Chimeric hirudin proteins
05/14/2010WO2010054405A1 Novel lipids and compositions for the delivery of therapeutics
05/14/2010WO2010054401A1 Novel lipids and compositions for the delivery of therapeutics
05/14/2010WO2010054384A1 Lipids and compositions for the delivery of therapeutics
05/14/2010WO2010054321A2 Methods of treating autoimmune disorders and/or inflammatory disorders
05/14/2010WO2010054238A1 Factor viii formulations
05/14/2010WO2010054093A1 Formulations for the treatment of acute herpes zoster pain
05/14/2010WO2010053596A1 Bispecific intracellular delivery vehicles
05/14/2010WO2010053572A2 Aminoalcohol lipidoids and uses thereof
05/14/2010WO2010053337A2 Slow-release particle and a production method therefor
05/14/2010WO2010053335A2 Method for producing powder containing nanoparticles of insoluble drug, powder produced thereby and pharmaceutical composition containing same
05/14/2010WO2010053140A1 Hyaluronic acid derivative and pharmaceutical composition thereof
05/14/2010WO2010052879A1 Aqueous composition containing follicle-stimulating hormone
05/14/2010WO2010052430A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine
05/14/2010WO2010052243A2 Neurotensin-derived branched peptides and uses thereof
05/14/2010WO2010052228A1 Hla-g proteins and pharmaceutical uses thereof
05/14/2010WO2010034089A3 Preparation method of injectable biodegradable polymer
05/14/2010WO2010033884A3 Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
05/14/2010WO2010033222A3 Polymer conjugates of ziconotide peptides
05/14/2010WO2010033215A3 Polymer conjugates of aod-like peptides
05/14/2010WO2010030995A3 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface body lumens
05/14/2010WO2010011605A3 Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
05/14/2010WO2010010531A3 Composition for controlling increase in blood glucose
05/14/2010WO2009156991A3 Glycerophospholipids for the improvement of cognitive functions
05/14/2010WO2009152167A3 Delivery of therapeutics
05/14/2010WO2009106848A3 Intracellular enzyme and receptor modulation
05/14/2010WO2009083664A8 Novel taxoid-based compositions
05/14/2010CA2742955A1 Bispecific intracellular delivery vehicles
05/14/2010CA2742954A1 Aminoalcohol lipidoids and uses thereof
05/14/2010CA2742831A1 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems
05/14/2010CA2742808A1 Mesothelin antibody protein fusions and methods of use
05/14/2010CA2742718A1 Pharmaceutical aerosol composition
05/14/2010CA2742680A1 Pharmaceutical compositions for release control of methylphenidate
1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 1712